Biogen Pharmachem Industries Ltd
Incorporated in 1995, Biogen Pharmachem Industries Ltd is in the business of trading
in shares and securities.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
- Reg. 34 (1) Annual Report. 25 Aug
- Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (LODR) Regulations, 2015 25 Aug
- Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 25 Aug
-
Nil Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue
23 Jul - No deviation in utilization of Rs 25 crore raised via preferential issue as of June 30, 2025.
-
Regulations 30, 33 And Other Applicable Provisions Of The SEBI (LODR) Regulations, 2015
23 Jul - Biogen Pharmachem reports Q1 FY26 unaudited profit of Rs.134.48 lacs, approved by board on July 23, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
BPIL is engaged in the business of trading in shares and securities in the present and future markets. It trades in commodities, including agro-based and precious metals, and other goods. The company also provides stock broking and consulting services. In addition, it generates trades and sells wind power